2.491

1.63% 0.031

Annovis Bio Inc (ANVS)

Überblick Nachrichten Preisverlauf Warum fällt ANVS? Forum Prognose

Schlusskurs vom Vortag:

$2.46

Offen:

$2.44

24-Stunden-Volumen:

154.83K

Relative Volume:

0.33

Marktkapitalisierung:

$66.20M

Einnahmen:

Nettoeinkommen (Verlust:

$-24.88M

KGV:

-1.6791

EPS:

-1.4835

Netto-Cashflow:

$-24.98M

1W Leistung:

+0.40%

1M Leistung:

+5.49%

6M Leistung:

+0.81%

1J Leistung:

+51.52%

1-Tages-Spanne:

$2.44

$2.56

1-Wochen-Bereich:

$2.4101

$2.71

52-Wochen-Spanne:

$1.11

$5.50

Annovis Bio Inc Stock (ANVS) Company Profile

Firmenname

Annovis Bio Inc

Sektor

Healthcare (1118)

Branche

Biotechnology (616)

Telefon

484-875-3192

Adresse

101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-03-20

Neueste SEC-Einreichungen

ANVS's Discussions on Twitter

Compare ANVS vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ANVS Annovis Bio Inc	2.4979	65.20M	0	-24.88M	-24.98M	-1.4835
VRTX Vertex Pharmaceuticals Inc	473.55	121.46B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	746.82	78.93B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	705.63	43.87B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.04	42.07B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	283.89	31.65B	5.36B	287.73M	924.18M	2.5229

Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-10	Herabstufung	D. Boral Capital	Buy → Hold
2024-10-25	Hochstufung	Maxim Group	Hold → Buy
2023-12-29	Eingeleitet	Canaccord Genuity	Buy
2021-07-07	Bestätigt	Maxim Group	Buy

Annovis Bio Inc Aktie (ANVS) Neueste Nachrichten

Mar 11, 2026

Published on: 2026-03-11 14:44:25 - baoquankhu1.vn

Mar 11, 2026

Mar 10, 2026

Annovis Bio to present buntanetap clinical data at AD/PD 2026 conference - MSN

Mar 10, 2026

Annovis Bio to Present Buntanetap Clinical Data at AD/PD 2026 Conference - MyChesCo

Mar 10, 2026

Mar 08, 2026

Support Test: Is Annovis Bio Inc. stock technically oversold2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn

Mar 08, 2026

Mar 06, 2026

Momentum Shift: What makes Annovis Bio Inc stock attractive todayM&A Rumor & Fast Gain Stock Tips - baoquankhu1.vn

Mar 06, 2026

Annovis Bio Stock Price Drops 8.5%What's Next? - National Today

Mar 06, 2026

Annovis Bio (NYSE:ANVS) Stock Price Down 8.5%What's Next? - MarketBeat

Mar 06, 2026

Mar 04, 2026

Annovis CEO eyes spring breakthrough for Alzheimer’s drug - Longevity.Technology

Mar 04, 2026

Mar 03, 2026

Annovis Announces Two Presentations at the AD/PD 2026 International Conference - Bitget

Mar 03, 2026

Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference - The Manila Times

Mar 03, 2026

Mar 01, 2026

AI Stocks: Will Annovis Bio Inc. benefit from rising consumer demandTrade Exit Report & Low Risk High Win Rate Picks - baoquankhu1.vn

Mar 01, 2026

Feb 28, 2026

Annovis Bio Stock: Can Fresh Alzheimer’s Data Spark the Next Big Short Squeeze? - AD HOC NEWS

Feb 28, 2026

Feb 27, 2026

ANVS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 27, 2026

Feb 26, 2026

Annovis nears FDA threshold for Alzheimer's drug as CEO eyes spring milestone - The Business Journals

Feb 26, 2026

Feb 24, 2026

Tech Rally: Whats the analyst consensus on Annovis Bio Inc2025 Buyback Activity & AI Powered Market Entry Ideas - baoquankhu1.vn

Feb 24, 2026

Feb 23, 2026

Annovis Bio (ANVS): Alzheimer’s Data, Cash Burn and Why Traders Are Split - AD HOC NEWS

Feb 23, 2026

Feb 20, 2026

Should you avoid Annovis Bio Inc. stock right nowEarnings Recap Summary & Weekly Setup with ROI Potential - mfd.ru

Feb 20, 2026

Trading Action: Will Annovis Bio Inc. benefit from seasonalityJuly 2025 Weekly Recap & Technical Pattern Based Signals - mfd.ru

Feb 20, 2026

Is Annovis Bio Inc. a defensive stockJuly 2025 Final Week & Safe Capital Growth Trade Ideas - mfd.ru

Feb 20, 2026

Feb 19, 2026

Aug Analyst Calls: Will Annovis Bio Inc benefit from seasonalityQuarterly Market Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Feb 19, 2026

Feb 18, 2026

Rate Hike: Can ADSE keep up with sector leadersJuly 2025 Setups & Verified Entry Point Detection - baoquankhu1.vn

Feb 18, 2026

Feb 17, 2026

Malvern-based Annovis continues phase 3 Alzheimer’s trial after safety review - MSN

Feb 17, 2026

Malvern-Based Annovis Continues Phase 3 Alzheimer’s Trial After Safety Review - MyChesCo

Feb 17, 2026

Feb 15, 2026

Will Annovis Bio Inc. stock rally after Fed decisionsJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - mfd.ru

Feb 15, 2026

Feb 14, 2026

Can Annovis Bio Inc. disrupt its industryJuly 2025 Institutional & Real-Time Volume Triggers - mfd.ru

Feb 14, 2026

Feb 13, 2026

ANVS Should I Buy - Intellectia AI

Feb 13, 2026

Guidance Update: Will Annovis Bio Inc. stock recover after earningsJuly 2025 Highlights & Low Risk Growth Stock Ideas - mfd.ru

Feb 13, 2026

Feb 12, 2026

Annovis Bio Advances Alzheimer’s Phase 3 Trial After Safety Nod - TipRanks

Feb 12, 2026

Annovis Bio, Inc. Secures DSMB Approval for Phase 3 Trial - TradingView

Feb 12, 2026

Annovis Bio Receives Positive Safety Recommendation from DSMB for Buntanetap in Alzheimer's Phase 3 Trial - Quiver Quantitative

Feb 12, 2026